Fig. S1. Sdc4 expression during mouse development. (A-D)
Transverse sections through E8.5 and E9.5 embryos after whole-mount in situ hybridization with an antisense RNA probe for Sdc4. (A) At E8.5, Sdc4 is expressed in the foregut diverticulum (arrowhead) and in the developing heart tube (arrow). At E9.5, Sdc4 is strongly expressed in the cephalic mesenchyme (arrowhead in B) and in the hindgut (arrowhead in C and D). Scale bars: 100 μm in A; 200 μm in B,C; 50 μm in D. 
;Vangl2
Lp/+ mouse. Compared with the sacral spina bifida (see Fig. 2B ), this more severe neural tube defect extends further rostrally, into the lumbar level of the body axis. Open vertebrae are visible extending across the midline (arrows in expanded view), indicating that the overlying spinal cord tissue has completely degenerated at this level. A sharply flexed tail is associated with the spina bifida.
Fig. S4. Specificity of morpholinos against Vangl2.
The specificity of the morpholinos against Vangl2 was demonstrated by rescue experiments using synthetic mRNA for Vangl2. Eight-cell stage Xenopus embryos were co-injected with the indicated amounts of morpholinos against xVangl2-MO and synthetic mRNA for an epitope-tag Vangl2 and neural tube closure defects were quantified at stage 20. Phenotypes were classified as type I (severe gastrulation and neural tube closure defects; red) and type II (impairment of neural tube closure; green). The graph summarizes two independent experiments, with numbers of embryos given at the top of each bar. Lp/+ background adversely affects pre/postnatal survival. Chi-square analysis of proportion of each genotype versus 25% expectation: significant; P<0.01 (chi-square = 6.77, dof = 1). 
